Proteostasis Therapeutics, Inc. announced that it has appointed Helen M. Boudreau as the company's Chief Financial Officer and Treasurer, effective July 25, 2017. Ms. Boudreau is stepping down as a Director from the Proteostasis Board of Directors, a position she has held since February 2016, to accept the executive management role. In Helen Boudreau most recent management role, she served as the Chief Financial Officer of FORMA Therapeutics, Inc., a clinical stage biotechnology company.